Newly Funded Effort Aims for Vaccine against Valley Fever

UCI Awarded $13.8 Million Federal Contract to Profile Lipid Nanoparticles

Link Type
Funded-research
Media Type
Article
Publish or Event Date
Link URL
https://news.uci.edu/2022/09/26/uci-awarded-13-8-million-federal-contract-to-profile-lipid-nanoparticles/
Research Institution
University of California, Irvine
Short Title
UCI Awarded $13.8 Million Federal Contract to Profile Lipid Nanoparticles
Content Coordinator
Claudia Wair
Content Manager
Catey Laube Macdonald

Researchers from NAU, Washington Tackling an Elusive Valley Fever Vaccine

The Longer the Bootcamp, the Better the Antibodies

How Human Cells Become Zika Virus Factories

Phase 1/2 Open-label Trial of Safety and Immunogenicity of Recombinant Varicella Zoster Virus Vaccine (RZV) in People with HIV Who Have a CD4 Count < 300 or ≥ 300 and a Healthy Control Population

The purpose of this study it to learn how Shingrix affects the immune response in people with HIV.

Contact Information

Volunteer or get more information 
Toll free: 1-800-411-1222 
TTY: 1-866-411-1010 
Se habla español 
  
Email: prpl@mail.cc.nih.gov  

Urgent Competitive Revision to Existing NIH Grants and Cooperative Agreements (Urgent Supplement, Clinical Trial Optional)

 The National Institutes of Health (NIH) hereby notify Principal Investigators on specific types of NIH research grants, listed in the Urgent Notice of Special Interest (NOSI) that funds may be available for competitive revisions to meet immediate needs to help address a specific public health crisis in a timely manner, but that were unforeseen when the new or renewal application or grant progress report for non-competing continuation support was submitted.  Applications for Urgent Competitive Revisions will be routed directly to the NIH awarding component listed on the NoA of the

Zika Virus Information for Researchers

NIAID is conducting and supporting research to find new and improved ways to diagnose, treat, and prevent Zika virus infections. Through the information offered here, the scientific community can learn about NIAID funding opportunities, programs, and networks to further research and encourage collaboration. This section also provides information on resources provided by NIAID to advance product development.

Support for Research

Funding Opportunities

NIAID is always accepting researcher-initiated applications. Connect with NIAID program officers about potential or related funding for Zika virus research.

Program Officers 

  • L. Jean Patterson, Ph.D., Acting Branch Chief
  • Mindy Davis, Ph.D., Acting Section Chief, Translational Research; Program Officer, Antiviral Discovery
  • Ruth Florese, Ph.D., Program Officer, Clinical Research, Virology Branch
  • Kaitlyn Morabito, Ph.D., Program Officer, Flaviviruses, Virology Branch
  • Sara Woodson, Ph.D., Team Lead, Centers for Research in Emerging Infectious Diseases (CREID) Network
Search all NIAID funding opportunities and announcements

Resources for Researchers

NIAID offers resources such as technologies available for licensing or collaboration, computer applications, and other tools and services to the general scientific community to advance basic, preclinical, and clinical research. See all resources for Zika virus researchers. 

For researchers developing products such as diagnostics, vaccines, or drug therapies, NIAID provides repositories, genomics and bioinformatics services and tools, preclinical studies, and clinical evaluation that support each stage of the product development pathway. Read more about NIAID's support for infectious disease product developers.

Programs & Networks

The NIAID-funded Centers of Excellence for Translational Research program is funding innovative research to develop novel therapeutics and vaccines against Zika virus.

NIAID also funds the Centers for Research in Emerging Infectious Diseases (CREID), a global network of multidisciplinary investigations into how and where viruses and other pathogens can emerge from wildlife and spillover to cause disease in people. Research is led by 10 Centers and one Coordinating Center and involves collaborations with peer institutions in the United States and 28 other countries.

Read more about Zika research programs and networks funded by NIAID

Connect With Other Researchers

Search for scientists at NIAID who research Zika virus in the scientist directory.

Search for scientists funded by NIAID who research Zika virus on RePORTER.

Publications

See recent articles on Zika in PubMed.

Follow Us on Social Media

@NIAIDNews on X
Resources for Researchers email updates
NIAID on LinkedIn
NIAID on Facebook
NIAID on Instagram

Tuberculosis Information for Researchers

NIAID supports a comprehensive portfolio of research covering basic, translational, and clinical studies to better understand the national history of tuberculosis (TB) and the development of drug resistance. NIAID also provides resources and animal models to investigators worldwide to facilitate biomedical research and help move drugs, vaccines, and diagnostics closer to patients.

Through the information offered here, researchers can learn about the science being conducted at NIAID and by NIAID-funded researchers. Researchers seeking funding can access opportunities to further their own research, while NIAID and NIH grantees can find out about available resources outside of specific funding opportunities. Recent publications, active networks, and ways to connect with other researchers are also available.

NIAID Strategic Plan for Tuberculosis Research, 2024 Update

Tuberculosis is the second leading infectious cause of death worldwide. In the updated strategic plan, NIAID details four strategic priorities that are critical to the development and evaluation of the knowledge and tools needed to end TB globally. 

Resources for Researchers

NIAID offers resources such as technologies available for licensing or collaboration, computer applications, and other tools and services to the general scientific community to advance basic, preclinical, and clinical research. See all resources for TB researchers. 

For researchers developing products such as diagnostics, vaccines, or drug therapies, NIAID provides repositories, genomics and bioinformatics services and tools, preclinical studies, and clinical evaluation that support each stage of the product development pathway. Read more about NIAID's support for infectious disease product developers.

Funding Opportunities

NIAID is always accepting researcher-initiated applications. Look up NIAID program officers in the NIH Enterprise Directory who work in your specialty area to discuss potential or related funding for tuberculosis research.

Program Officers

  • Dr. Jim Boyce – Drug Discovery
  • Dr. Katrin Eichelberg – Immunology and Vaccines
  • Dr. Daniel Frank – HIV-TB Clinical Research
  • Dr. Alison Kraigsley – Pathogen Biology
  • Dr. Karen Lacourciere – Diagnostics, Genetics, and Epidemiology
  • Dr. Barbara Laughon – Advanced Drug Development
  • Dr. Susana Mendez – Mycobacterial Biology and Pathogenesis
  • Andre McBride – Preclinical Services
  • Dr. Lakshmi Ramachandra – Tuberculosis Research Advancement Centers (TRACs)
  • Dr. Sudha Srinivasan – HIV-TB Clinical Research

Programs & Networks

Read more about NIAID-supported collaborations and partnerships that further tuberculosis research

Connect With Other Researchers

Search for scientists at NIAID who research TB in the scientist directory.

Search for scientists funded by NIAID who research TB on RePORTER. 

Follow Us on Social Media

@NIAIDNews on X
Resources for Researchers email updates
NIAID on LinkedIn
NIAID on Facebook
NIAID on Instagram

Cambodia ICER Program

NIAID International Center of Excellence in Research (ICER) Cambodia is a collaborative research partnership between NIAID and the Cambodian Ministry of Health, specifically the National Center for Parasitology, Entomology, and Malaria Control, the Cambodian Department of Communicable Disease Control, the National Institute of Public Health, and the University of Health Sciences. ICER Cambodia consists of a team of U.S.

Subscribe to